HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,593 | +4.9% | 520,124 | -0.3% | 0.01% | +16.7% |
| Q2 2023 | $44,400 | +10.5% | 521,489 | +7.4% | 0.01% | 0.0% |
| Q1 2023 | $40,198 | +5.3% | 485,756 | +0.1% | 0.01% | 0.0% |
| Q4 2022 | $38,185 | -99.9% | 485,505 | +19.6% | 0.01% | +20.0% |
| Q3 2022 | $30,055,000 | +45.2% | 405,973 | +27.8% | 0.01% | +66.7% |
| Q2 2022 | $20,702,000 | +15.2% | 317,619 | +11.7% | 0.00% | +50.0% |
| Q1 2022 | $17,977,000 | +4.5% | 284,353 | -12.3% | 0.00% | 0.0% |
| Q4 2021 | $17,204,000 | -30.6% | 324,360 | -7.7% | 0.00% | 0.0% |
| Q3 2021 | $24,796,000 | -33.1% | 351,265 | -36.9% | 0.00% | -33.3% |
| Q2 2021 | $37,073,000 | -39.5% | 556,314 | +0.8% | 0.00% | -50.0% |
| Q1 2021 | $61,286,000 | -15.1% | 552,072 | -9.2% | 0.01% | -14.3% |
| Q4 2020 | $72,204,000 | +35.0% | 608,032 | -0.8% | 0.01% | +16.7% |
| Q3 2020 | $53,498,000 | -4.3% | 613,162 | -1.7% | 0.01% | -14.3% |
| Q2 2020 | $55,883,000 | -10.9% | 623,973 | -0.9% | 0.01% | -30.0% |
| Q1 2020 | $62,726,000 | -12.8% | 629,401 | +0.6% | 0.01% | +11.1% |
| Q4 2019 | $71,917,000 | -9.0% | 625,910 | -0.1% | 0.01% | -18.2% |
| Q3 2019 | $79,052,000 | +8.8% | 626,701 | +3.8% | 0.01% | +10.0% |
| Q2 2019 | $72,628,000 | +63.7% | 603,523 | +19.0% | 0.01% | +42.9% |
| Q1 2019 | $44,369,000 | -20.6% | 507,188 | -9.2% | 0.01% | -22.2% |
| Q4 2018 | $55,891,000 | -41.0% | 558,633 | -32.4% | 0.01% | -35.7% |
| Q3 2018 | $94,702,000 | +88.8% | 826,510 | +47.8% | 0.01% | +75.0% |
| Q2 2018 | $50,148,000 | -23.2% | 559,189 | -37.4% | 0.01% | -20.0% |
| Q1 2018 | $65,312,000 | -26.2% | 892,735 | -41.4% | 0.01% | -28.6% |
| Q4 2017 | $88,527,000 | -24.2% | 1,524,222 | -41.5% | 0.01% | -30.0% |
| Q3 2017 | $116,853,000 | -8.4% | 2,604,262 | -19.4% | 0.02% | -13.0% |
| Q2 2017 | $127,540,000 | -9.4% | 3,229,686 | -6.9% | 0.02% | -11.5% |
| Q1 2017 | $140,814,000 | -35.2% | 3,470,891 | -35.7% | 0.03% | -39.5% |
| Q4 2016 | $217,158,000 | +8.9% | 5,401,931 | -1.9% | 0.04% | +7.5% |
| Q3 2016 | $199,319,000 | +28.0% | 5,504,523 | +2.5% | 0.04% | +21.2% |
| Q2 2016 | $155,709,000 | -4.5% | 5,371,130 | +15.2% | 0.03% | -5.7% |
| Q1 2016 | $163,095,000 | +89.2% | 4,662,510 | +74.4% | 0.04% | +94.4% |
| Q4 2015 | $86,203,000 | +44.1% | 2,673,780 | +44.4% | 0.02% | +38.5% |
| Q3 2015 | $59,828,000 | -19.6% | 1,851,127 | +2.9% | 0.01% | -13.3% |
| Q2 2015 | $74,415,000 | +28.3% | 1,799,200 | +39.3% | 0.02% | +25.0% |
| Q1 2015 | $58,004,000 | +20.6% | 1,291,280 | +0.5% | 0.01% | +20.0% |
| Q4 2014 | $48,088,000 | +35.7% | 1,285,080 | +26.6% | 0.01% | +25.0% |
| Q3 2014 | $35,450,000 | +6108.4% | 1,015,180 | +6174.3% | 0.01% | – |
| Q2 2014 | $571,000 | -6.7% | 16,180 | -13.8% | 0.00% | – |
| Q1 2014 | $612,000 | -61.3% | 18,780 | -50.0% | 0.00% | – |
| Q4 2013 | $1,582,000 | +163.2% | 37,560 | +149.1% | 0.00% | – |
| Q3 2013 | $601,000 | -51.8% | 15,080 | -50.0% | 0.00% | – |
| Q2 2013 | $1,248,000 | – | 30,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |